減肥和肥胖管理市場規模- 產品和服務（補充劑、藥物[GLP-1 受體激動劑、脂肪酶抑製劑、血清素受體激動劑]、設備[健身監測、外科]、服務）、年齡層與全球預測，2024 年- 2032 年

Weight Loss and Obesity Management Market Size - Product and Services (Supplement, Drug [GLP-1 Receptor Agonist, Lipase Inhibitor, Serotonin Receptor Agonist], Equipment [Fitness Monitoring, Surgical], Service), Age Group & Global Forecast, 2024 - 2032

出版日期: 2024年05月30日 | 出版商:

Global Market Insights Inc. | 英文 86 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於人們對肥胖相關健康風險（如糖尿病、心血管問題和高血壓）的認知不斷提高，減肥和肥胖管理市場在 2024 年和 2032 年的複合年成長率將超過 8.6%。據世界衛生組織 (WHO) 稱，到 2022 年，將有超過 6.5 億成年人肥胖，凸顯了採取有效干預措施的緊迫性。與此同時，久坐生活方式和不良飲食習慣的激增正在加劇肥胖率。多樣化的減肥計劃、膳食補充劑和健身器材的出現，滿足了追求有效體重管理和改善健康的個人的需求，將有利於市場前景。

微創手術和創新健身設備等技術進步正在提升產業佔有率。人們擴大採用數位健康平台和行動應用程式來進行個人化體重管理和即時追蹤。例如，美國心臟協會的一份報告強調，數位健康干預措施可以平均減輕 3.5% 的體重。全球範圍內旨在控制肥胖率和促進更健康生活的政府措施將推動需求。

整個減重和肥胖管理市場根據產品和服務、年齡層和地區進行分類。

由於人們越來越意識到體力活動對於維持健康體重的重要性，設備領域正在受到巨大的關注。隨著越來越多的人採用以健身為中心的生活方式，由於便利性和可及性，人們更喜歡家庭健身器材。此外，健身技術的進步，例如提供即時追蹤和個人化運動計畫的智慧健身機和穿戴式設備，使這些產品對尋求有效且有吸引力的體重管理方法的消費者更具吸引力。

由於兒童肥胖症盛行率不斷上升，兒童肥胖症已成為全球主要的公共衛生問題，因此兒童市場在預測期內將顯著成長。家長和教育工作者對與兒童肥胖相關的長期健康風險的認知不斷提高，推動了針對年輕群體量身定做的專門體重管理計劃和產品的需求。此外，旨在促進兒童體育活動和健康飲食習慣的政府舉措和學校計劃預計將促進該細分市場的成長。

由於肥胖症（尤其是兒童肥胖症）盛行率不斷上升，到 2032 年，歐洲減肥和肥胖管理行業的複合年成長率將強勁。肥胖率的上升與久坐的生活方式、不健康的飲食習慣和高熱量食物的消費增加有關。此外，人們越來越認知並採用體重管理計劃和手術干預措施，這得到了旨在促進更健康生活方式的政府舉措的進一步支持。隨著消費者尋求更安全、更有效的減肥解決方案，天然和有機體重管理補充劑的日益普及也促進了行業的成長

產業生態系統分析
產業影響力
- 成長動力
  - 肥胖和超重的盛行率不斷增加
  - 肥胖治療藥物的批准不斷增加
  - 提高全民健身意識
  - 對治療極度肥胖的減重手術的需求不斷成長
- 產業陷阱與挑戰
  - 不良事件發生率增加
  - 營養保健品缺乏標準化
成長潛力分析
未來市場趨勢
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品和服務分類，2021 - 2032 年

主要趨勢
補充品
藥品
- GLP-1受體激動劑
- 脂肪酶抑制劑
- 組合藥物
- 血清素受體激動劑
- 其他藥品
裝置
- 健身器材
- 健身監測設備
- 手術設備
- 其他設備
服務

第 6 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
成人
孩子們

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Allurion
Amgen Inc.
Boehringer Ingelheim International GmbH
Eisai Co., Ltd.
Equinox Inc.
FOUND
Herbalife International of America, Inc.
Johnson & Johnson Services Inc. (Ethicon Inc.)
Kellogg Co.
Lifetime Fitness Inc.
Medtronic plc
Novo Nordisk A/S
Nutrisystem, Inc.
OptiBiotix Online
PRISTYN CARE
Roman Health Ventures Inc.
Takeda Pharmaceutical Company Ltd.
Teleflex Inc.
VIVUS LLC.
WW International, Inc.

簡介目錄

Product Code: 9706

The Weight Loss and Obesity Management Market will register over 8.6% CAGR over 2024 and 2032, driven by the heightened awareness of the health risks linked to obesity, such as diabetes, cardiovascular issues, and hypertension. According to the World Health Organization (WHO), over 650 million adults were obese in 2022, underscoring the urgency for effective interventions. Concurrently, a surge in sedentary lifestyles and poor dietary habits is amplifying obesity rates. The availability of diverse weight loss programs, dietary supplements, and fitness equipment, catering to individuals striving for effective weight management and better health will favor the market outlook.

Technological strides, like minimally invasive surgeries and innovative fitness devices, are bolstering industry share. There is increasing adoption of digital health platforms and mobile apps for personalized weight management and real-time tracking. For instance, a report by the American Heart Association highlighted that digital health interventions could reduce body weight by an average of 3.5%. The government initiatives worldwide, aimed at curbing obesity rates and promoting healthier living, will push the demand.

The overall weight loss and obesity management market is classified based on product & services, age group, and region.

The equipment segment is witnessing significant traction due to the rising awareness of the importance of physical activity in maintaining a healthy weight. As more individuals adopt fitness-centric lifestyles, there is a preference for home-based exercise equipment, driven by convenience and accessibility. Additionally, advancements in fitness technology, such as smart exercise machines and wearable devices that offer real-time tracking and personalized workout plans, are making these products more appealing to consumers seeking effective and engaging ways to manage their weight.

The children segment is poised to display significant growth over the forecast period, owing to the rising prevalence of childhood obesity, which has become a major public health concern globally. Increasing awareness among parents and educators about the long-term health risks associated with obesity in children is driving demand for specialized weight management programs and products tailored to younger age groups. Furthermore, government initiatives and school-based programs aimed at promoting physical activity and healthy eating habits among children are expected to bolster the segment growth.

Europe weight loss and obesity management industry will register strong CAGR through 2032, driven by the increasing prevalence of obesity, especially among children. This rise in obesity rates is linked to sedentary lifestyles, unhealthy eating habits, and increased consumption of high-calorie foods. Additionally, there is a growing awareness and adoption of weight management programs and surgical interventions, which are further supported by government initiatives aimed at promoting healthier lifestyles. The rising popularity of natural and organic weight management supplements also contributes to the industry growth, as consumers seek safer and more effective solutions for weight loss

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of obesity and overweight
  - 3.2.1.2 Growing approval for obesity treatment drugs
  - 3.2.1.3 Increasing awareness towards fitness activities
  - 3.2.1.4 Growing demand for bariatric surgery to treat extreme obesity
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Increasing incidence of adverse events
  - 3.2.2.2 Lack of standardization in nutraceuticals
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Supplements
5.3 Drugs
- 5.3.1 GLP-1 receptor agonists
- 5.3.2 Lipase inhibitors
- 5.3.3 Combination drugs
- 5.3.4 Serotonin receptor agonists
- 5.3.5 Other drugs
5.4 Equipment
- 5.4.1 Fitness equipment
- 5.4.2 Fitness monitoring equipment
- 5.4.3 Surgical equipment
- 5.4.4 Other equipment
5.5 Services

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Adult
6.3 Children

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa